KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,000 | -66.7% | 690 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $6,000 | -25.0% | 690 | +5.2% | 0.00% | 0.0% |
| Q1 2015 | $8,000 | -11.1% | 656 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $9,000 | 0.0% | 656 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $9,000 | 0.0% | 656 | +5.1% | 0.00% | 0.0% |
| Q2 2014 | $9,000 | 0.0% | 624 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $9,000 | 0.0% | 624 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $9,000 | – | 624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |